Topic

semaglutide

Latest news

17 Oct
Semaglutide reduced epigenetic signs of biological aging in a randomized trial
A randomized, double-blind, placebo-controlled trial found weekly semaglutide injections slowed accumulation of biological aging markers measured by multiple epigenetic clocks. The study analyzed 108 adults with HIV-associated lipohypertrophy over a 32-week treatment period and was reported by researchers at UC San Diego and partner institutions in Nature Communications.
Research · 1 source

No articles about semaglutide yet.